CORRECTION: MabThera recommended in Scotland

Scottish physicians are now able to prescribe MabThera (rituximab) on the NHS, following a positive recommendation by the Scottish Medicines Consortium (SMC). MabThera was...

GPs need swine flu guidance

A poll of GPs by has revealed that, so far, only 9% of GPs in the UK have been given regular, clear and concise...

Tamiflu discount for poorer countries

Roche is to provide its antiviral Tamiflu at a lower price to developing countries as part of a new initiative. Under the Tamiflu Reserves...

Viruses resistant to Tamiflu identified

Several cases of the H1N1 ‘swine flu’ virus have emerged that are resistant to antiviral drug Tamiflu (oseltaminvir). WHO has been informed by...

Novartis joins fight against malaria

Novartis has become the first healthcare company to join United Against Malaria (UAM), a pan-Africa campaign to end malaria-related deaths and suffering by 2015....

Novo Nordisk launches Victoza in UK

Novo Nordisk’s Victoza is now available for type 2 diabetes patients in the UK, following EU approval. Victoza is the first once-daily human Glucagon-like...

Best-selling drugs cheaper in Europe

European prices of 170 best-selling drugs averaged 40% less than US prices in 2008, recent research has revealed. Within Europe, it was found,...

Study confirms Cervarix efficacy

The largest efficacy trial of a cervical cancer vaccine has shown that Cervarix protects against the five most common cancer-causing virus types. The...

Positive CHMP opinion for Javlor

The CHMP has issued a positive opinion recommending EU marketing authorisation for Javlor from Laboratoires Pierre Fabre. The drug has been recommended for...

EU lung cancer approval for Alimta

Alimta (pemetrexed for injection) has become the first agent approved in Europe as maintenance therapy for advanced, nonsquamous non-small cell lung cancer. The European...

Latest articles

Image of business people nurturing plants growing with light bulbs at the top to show Primary care networks and mental health services post COVID-19

Primary care networks and mental health services post COVID-19

Joint working between primary care networks and providers of mental health services must accelerate if the NHS is to help the huge increase in...
image of the European flag and the Union flag with arrows point them in different directions to show Preparing pharma for the end of Brexit transition: ABPI response

Preparing pharma for end of Brexit transition: ABPI response

The Department of Health and Social Care has published a letter setting out the Government’s plan and requests of industry and the wider supply chain...
Image f a healthcare professional holding tablets to show Common chronic pain treatments 'can do more harm than good'

Common chronic pain treatments ‘can do more harm than good’

A number of commonly used drug treatments for chronic primary pain have little or no evidence that they work and shouldn’t be prescribed, NICE...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
image of the European flag and the Union flag with arrows point them in different directions to show Preparing pharma for the end of Brexit transition: ABPI response

Preparing pharma for end of Brexit transition: ABPI response

The Department of Health and Social Care has published a letter setting out the Government’s plan and requests of industry and the wider supply chain...
Woman holding swab: COVID-19 pandemic

COVID-19: Pharma on the frontline

Pharma stepped up to support the NHS, the country and the World during the COVID-19 pandemic. Pf brings you some examples of pharma on...
Image of two small people signing and over-sized contract with rubber stamp at side to show Orphan Drug Designation granted to tinostamustine in EU for very rare form of leukaemia

Orphan Drug Designation granted to tinostamustine in EU for very rare form of leukaemia

Mundipharma has announced that the European Commission (EC) has now adopted the European Medicines Agency (EMA) Committee for Orphan Medicinal Products recommendation to grant...
Medical tests: rapid change of clinical research

Rapid change COVID-19 & UK clinical research

Dr Matthew Hallsworth, Head of External Relations at the National Institute for Health Research, looks how COVID-19 has brought about rapid change of clinical...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription